Approval · Notice of Compliance 34440 · 2024
VALACYCLOVIR: Notice of Compliance 34440
Issued November 26, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34440
- Date
- November 26, 2024
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
- Canadian reference product
- VALTREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALACYCLOVIR | 02553511 | Marketed |
Medicinal ingredients
- VALACYCLOVIR 1,000 MG per TAB